Studies of apolipoprotein (a) promoter from subjects with different plasma lipoprotein (a) concentrations

Clinical Biochemistry

Volumn 36, Issue 4, 2003, Pages 241-246

  Wu, June H ^a   Lee, I Neng ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Apolipoprotein (a); DNA sequences; HepG2 cells; Luciferase assay; Nucleotide polymorphism; Plasma lipoprotein (a) concentration; Promoter activity

Indexed keywords

ADENINE; APOLIPOPROTEIN A; CYTOSINE; GUANINE; LUCIFERASE; NUCLEOTIDE; THYMINE;

ARTICLE; CONCENTRATION (PARAMETERS); DNA SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; MOLECULAR CLONING; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN FUNCTION;

EID: 0037841609     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(03)00002-X     Document Type: Article

References (25)

1. Murai A., Miyahara T., Fujimoto N., Matsuda M., Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease, and cerebral infarction. Atherosclerosis. 59:1986;199-204.
2. Wu J.H., Kao J.T., Wen M.S., Wu D. Coronary artery disease risk predicted by plasma concentrations of high-density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B, and lipoprotein (a) in a general Chinese population. Clin Chem. 39:1993;209-212.
3. Krempler F., Kostner G.M., Bolzano K., Sandhofer F. Turnover of lipoprotein (a) in man. J Clin Invest. 65:1980;1483-1490.
4. McLean J.W., Tomlinson J.E., Kuang W.J., et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature. 330:1987;132-137.
5. Lindahl G., Gersdorf E., Menzel H.J., Seed M., Humphries S., Utermann G. Variation in the size of human apolipoprotein (a) is due to a hypervariable region in the gene. Hum Genet. 84:1990;563-567.
6. Koschinsky M., Beisiegel U., Henne-Bruns D., Eaton D., Lawn R. Apo(a) size heterogeneity is related to variable number of repeat sequence in its mRNA. Biochem. 29:1990;640-644.
7. Frank S.L., Klisak I., Sparkes R.S., et al. The apolipoprotein (a) gene resides on human chromosome 6q26-27 in close proximity to the homologous gene for plasminogen. Hum Genet. 79:1988;352-356.
8. Wade D.P., Clarke J.G., Lindahl G.E., et al. 5′ control regions of the apolipoprotein (a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA. 90:1993;1369-1373.
9. Ichinose A. Multiple members of the plasminogen-apolipoprotein (a) gene family associated with thrombosis. Biochem. 31:1992;3113-3118.
10. Malgaretti N., Acquati F., Magnaghi P., et al. Characterization by yeast artificial chromosome cloning of the linked apolipoprotein (a) and plasminogen genes and identification of the apolipoprotein (a) 5′ flanking region. Proc Natl Acad Sci USA. 89:1992;11584-11588.
11. Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmler H.G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentration in plasma. J Clin Invest. 80:1987;458-465.
12. Wu J.H., Wen M.S., Lo S.K., Wu D. DNA polymorphisms of apolipoprotein B in the population of Taiwan. J Formos Med Assoc. 92:1993;330-335.
13. Hixson J.E., Britten M.L., Manis G.S., Rainwater D.L. Apolipoprotein (a) (apoa) glycoprotein isoforms result from size differences in apo(a) mRNA in Baboons. J Biol Chem. 264:1989;6013-6016.
14. Azrolan N., Gavish D., Breslow J.L. Plasma lipoprotein (a) concentration is controlled by apolipoprotein (a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a Cynomolgus monkey model. J Biol Chem. 266:1991;13866-13872.
15. Bopp S., Kochl S., Acquati F., et al. Ten allelic apolipoprotein [a] 5′ flanking fragments exhibit comparable promoter activities in HepG2 cells. J Lipid Res. 36:1995;1721-1728.
16. Amemiya H., Arinami T., Kikuchi S., et al. Apolipoprotein (a) seize and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease. Atherosclerosis. 123:1996;181-191.
17. Brazier L., Tiret L., Luc G., et al. Sequence polymorphisms in the apolipoprotein (a) gene and their association with lipoprotein (a) levels and myocardial infarction. The ECTIM study. Atherosclerosis. 144:1999;323-333.
18. Trommsdorff M., Koechl S., Lingenhel A., et al. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein (a) gene is associated with lipoprotein (a) plasma concentrations in Caucasians. J Clin Invest. 96:1995;150-157.
19. Mooser V., Mancini F.P., Bopp S., et al. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet. 4:1995;173-181.
20. Zysow B.R., Lindahl G.E., Wade D.P., Knight B.L., Lawn R.M. C/T polymorphism in the 5′ untranslated region of apolipoprotein (a) gene introduces an upstream ATG, and reduces in vitro translation. Arterioscler Thromb Vasc Biol. 15:1995;58-64.
21. Suzuki K., Kuriyama M., Saito T., Ichinose A. Plasma lipoprotein (a) levels and expression of the apolipoprotein (a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest. 99:1997;1361-1366.
22. Wade D.P., Puckey L.H., Knight B.L., Acquati F., Mihalich A., Taramelli R. Characterization of multiple enhancer regions upstream of the apolipoprotein (a) gene. J Biol Chem. 272:1997;30387-30399.
23. Weiher H., Konig M., Gruss P. Multiple point mutations affecting the simian virus 40 enhancer. Science. 219:1983;621-631.
24. Zenke M., Grundstrom T., Matthes H., et al. Multiple sequence motifs are involved in SV40 enhancer function. EMBO J. 5:1986;387-397.
25. Godbout R., Ingram R., Tilgman S.M. Multiple regulatory elements in the intergenic region between the α-fetoprotein and albumin genes. Mol Cell Biol. 6:1986;477-487.